Interpretation of 2023 2nd NCCN clinical practice guidelines in oncology-pancreatic adenocarcinoma
Journal Title: Journal of Surgery : Concepts & Practice - Year 2024, Vol 29, Issue 1
Abstract
Pancreatic adenocarcinoma, a severe digestive malignancy, is characterized by its poor prognosis. The National Comprehensive Cancer Network (NCCN) persistently refines its guidelines, integrating cutting-edge evidence-based medical insights to standardize the diagnostic and therapeutic strategies of pancreatic adenocarcinoma. The NCCN clinical practice guidelines in oncology-pancreatic adenocarcinoma were updated twice on May 4 and June 19, 2023, respectively. Compared to the 2022 predecessor, these two updates placed a particular emphasis on immunotherapy/targeted therapy, the introduction of NALIRIFOX regimen, and supplementary treatment protocols for patients with intermediate performance status. This article provided an interpretation of the latest updates to the NCCN clinical practice guidelines in oncology-pancreatic adenocarcinoma, integrating relevant evidence-based medical findings.
Authors and Affiliations
Jiahao CHEN, Chongyi JIANG
Keywords
Related Articles
- EP ID EP750935
- DOI 10.16139/j.1007-9610.2024.01.03
- Views 6
- Downloads 0
Study on oral microflora related to pancreatic cancer
Clinical value analysis of simple resection of pancreatic solid pseudopapillary tumor
[Objective] To explore the clinical application value of simple resection in the treatment of pancreatic solid pseudopapillary tumor(SPT). [Methods] Retrospective analysis of clinical and follow-up data of pancreatic SPT...
Research on standardized treatment of spontaneous rupture of hepatocellular carcinoma
Factors influencing early using enteral nutrition in severe burn patients
[Objective] To analyze the main factors affecting early using enteral nutrition and the effect of enteral nutrition within 72 h after burning on outcomes by presenting a retrospective cohort study of 11 years of hospital...
Chinese interpretation of European Neuroendocrine Tumour Society 2023 guidance for nonfunctioning pancreatic neuroendocrine tumours
This ENETS guidance for well-differentiated nonfunctioning pancreatic neuroendocrine tumours (NF-Pan-NET), which published on Journal of Neuroendocrinology (2023), has been developed by a multidisciplinary working group,...